[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
PTC Therapeutics, Inc.
Sentiment: XX%

Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% +13%
6 Months: XX% +10%
1 Year: XX% +13%
1-Year High: XXX% on 2024-11-01
1-Year Low: XX% on 2025-04-12
Most Supportive Themes
- Positive Analyst Ratings and Price Targets: (35%) Posts highlight positive analyst ratings and price targets for PTCT, suggesting potential upside.
- Mentions in AI and Momentum Stock Screeners: (30%) PTCT is featured in AI-driven stock rankings and momentum screeners, indicating positive technical and fundamental scores.
- Inclusion in Biotech Stock Lists: (15%) PTCT is included in lists of strong biotech stocks, suggesting positive sentiment within the biotech sector.
Most Critical Themes
- FDA Complete Response Letter for Vatiquinone: (40%) The FDA's rejection of the NDA for vatiquinone due to insufficient efficacy is a major negative catalyst.
Network engagement breakdown:
Network |
Positive |
% |
Neutral |
% |
Negative |
% |
X |
XXXXX |
XX% |
XXX |
XX% |
XX |
X% |
|
|
|
|
|
|
|
Total |
XXXXX |
XX% |
XXX |
XX% |
XX |
X% |